Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
May 19th, 2020
3.1K views
The opsono-adherence assay is an alternative method to the opsono-phagocytic killing assay to evaluate the opsonic functions of antibodies in vaccine development.
Overview
The Opsono-Adherence Assay evaluates the presence of functional opsonic antibodies produced after vaccination, correlating with vaccine efficacy. This assay is suitable for biological select agents and can be performed in BSL-1 or BSL-2 labs.
Key Study Components
Area of Science
- Immunology
- Vaccine Development
- Microbiology
Background
- The assay assesses opsonic functions of antibodies.
- It is an alternative to the opsono-phagocytic killing assay.
- Functional antibodies are crucial for evaluating vaccine efficacy.
- Safety protocols are essential when handling virulent strains.
Purpose of Study
- To analyze the efficacy of antibodies in vaccine development.
- To provide a safer alternative for evaluating opsonic functions.
- To correlate antibody presence with vaccine effectiveness.
Methods Used
- Opsonization of antibodies against bacterial capsules.
- Evaluation of antibody functionality without infecting animals.
- Use of inactivated strains under biosafety level conditions.
- Adherence assays to assess opsonic activity.
Main Results
- Functional opsonic antibodies were detected post-vaccination.
- Correlation established between antibody presence and vaccine efficacy.
- Assay demonstrated safety in BSL-1 and BSL-2 environments.
- Effective evaluation of antibodies against Bacillus anthracis.
Conclusions
- The Opsono-Adherence Assay is a reliable method for assessing vaccine-induced antibodies.
- It provides a safer alternative to traditional assays.
- Further studies can enhance understanding of opsonic functions in vaccine development.
Frequently Asked Questions
What is the Opsono-Adherence Assay?
It is an assay that evaluates the presence of functional opsonic antibodies after vaccination.
Why is this assay preferred for certain pathogens?
It can be performed in BSL-1 or BSL-2 labs, making it safer for use with select agents.
How does the assay correlate with vaccine efficacy?
The presence of functional antibodies has been shown to correlate with the efficacy of several licensed vaccines.
What safety measures are needed when conducting the assay?
Follow institutional safety and security procedures when working with encapsulated virulent strains.
Can the assay be performed without infecting animals?
Yes, it evaluates antibodies functionally without the need to infect animals.
What types of antibodies are evaluated in this assay?
Antibodies against bacterial capsules, such as those of Bacillus anthracis, are evaluated.
Executive Industry Relevance
The opsono-adherence assay provides a functional readout of vaccine-induced antibody activity against encapsulated pathogens, enabling early assessment of protective immunity without live pathogen challenge. By using inactivated bacteria and standardized cell lines, the assay supports reproducible evaluation of antibody efficacy across vaccine candidates and therapeutic candidates. This approach facilitates mechanistic de-risking in vaccine development by correlating anti-capsule antibody levels with functional opsonic activity, informing go/no-go decisions in preclinical pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates the therapeutic hypothesis that anti-capsule antibodies mediate protection by enabling pathogen adherence to phagocytes.
- Operational Value: Uses inactivated Bacillus anthracis and RAW 264.7 macrophages to allow safe, repeatable testing under BSL-2 conditions.
- Predictive Value: Correlates serum anti-capsule antibody titers with functional adherence, supporting biomarker qualification for vaccine efficacy.
Screening & Assay Development
- Scientific Value: Generates quantitative adherence data via automated fluorescence microscopy to assess antibody-mediated opsonization.
- Operational Value: Enables high-throughput screening of sera or monoclonal antibodies using 96-well plate format and standardized fixation and staining protocols.
- Reproducibility: Includes viability testing and sterility checks of fixed bacterial stocks to ensure assay consistency across runs.
Translational & Preclinical Research
- Scientific Value: Links antibody function to in vivo protection, as high anti-capsule antibody titers in non-human primates correlated with anthrax challenge survival.
- Operational Value: Uses heat-inactivated sera and complement addition to mimic physiological opsonization conditions.
- Translational Continuity: Supports evaluation of vaccine candidates by measuring functional antibody activity as a potential correlate of immunity.
Pipeline & Workflow Integration
The assay fits within the vaccine discovery workflow following antigen immunization and preceding in vivo challenge, providing an intermediate functional readout to prioritize candidates.
- Discovery Biology: Tests the mechanism of action of vaccine-induced antibodies by measuring their ability to opsonize encapsulated bacteria for phagocyte adherence.
- Screening: Enables standardized, quantitative assessment of antibody titers across immunized animal cohorts using fluorescence-based adherence readouts.
- Analytics: Generates adherence scores that correlate with serum antibody levels, supporting statistical comparison of vaccine formulations.
- Translational Research: Bridges in vitro antibody function to in vivo protection, as demonstrated in non-human primate challenge models.
- Enterprise Reuse: Platform can be adapted to other encapsulated pathogens by swapping bacterial strains and targeting relevant antigens.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic insight into antibody function beyond binding, assessing functional opsonic capacity critical for pathogen clearance.
- Operational Value: Uses inactivated pathogens and adherent cell lines to enable safe, scalable execution in standard containment labs.
- Strategic Value: Informs early go/no-go decisions by identifying vaccine candidates that elicit functional antibody responses, reducing reliance on late-stage challenge studies.
- Portfolio Impact: Supports risk-adjusted advancement by qualifying immunological correlates linked to protection in animal models.
Implementation Considerations
- Requires expertise in bacterial culture, encapsulation verification via India ink staining, and fluorescence microscopy.
- Dependent on access to biosafety-compliant facilities for initial pathogen inactivation and sterility validation.
- Necessitates standardized cell preparation (RAW 264.7) and opsonization protocols involving complement and serum dilution.
- Involves multi-step washing and fixation steps to remove unbound bacteria and preserve signal for imaging.
- Limited to pathogens where capsule-mediated adherence to phagocytes is a known mechanism of clearance.
Biopharma FAQs
Why does adherence measurement matter for opsonic antibody evaluation?
Adherence to phagocytes is a prerequisite for phagocytosis and killing, making it a functional readout of antibody-mediated opsonization. The assay quantifies this step to assess whether antibodies can promote pathogen uptake by immune cells. Increased adherence correlates with the presence of anti-capsule antibodies in immunized sera.
How does using inactivated pathogens support vaccine development workflows?
Inactivated Bacillus anthracis allows the assay to be performed in BSL-1 or BSL-2 labs after transfer from higher containment, enabling safer handling. Fixation preserves bacterial structure while eliminating infectivity, supporting standardized use across experiments. This approach facilitates work with select agents without requiring live pathogen handling.
What quantitative output does the assay generate to assess antibody function?
Automated fluorescence microscopy captures images of FITC-labeled bacteria adhering to macrophage monolayers, enabling counting of attached bacilli per cell. Increased fluorescence signal corresponds to higher bacterial adherence, which is scored to compare antibody activity across samples. This provides a measurable, imaging-based readout of opsonic function.
Why are replication and washing steps critical for assay reliability?
Multiple PBS washes remove unattached bacteria and excess reagents, reducing background signal and ensuring only firmly adhered pathogens are counted. Repeating fixation and staining steps minimizes nonspecific binding and preserves fluorescence integrity during imaging. These steps enhance reproducibility and signal-to-noise ratio in adherence measurements.
What statistical or analytical capabilities are needed before implementing this assay?
Teams require image analysis tools to quantify bacterial adherence per macrophage from fluorescence microscopy data. Statistical comparison of adherence scores across serum dilutions or vaccine groups enables evaluation of antibody titer-function relationships. Access to automated imaging platforms with z-stack and tiling capabilities supports high-throughput, standardized data capture.
Chapters in this video
0:04
Introduction
1:21
Plating of the Cell Line, RAW 264.7 and Bacterial Culture
6:29
FITC-labeling of Bacteria and Bacterial Opsonization
8:46
Adherence Assay and Fluorescent Labeling of Mammalian Cells
10:22
Microscopy
11:33
Results: Representative Micrographs Collected During an OAA Experiment to Evaluate the Efficacy of an Anthrax Vaccine
13:01
Conclusion
